Shire Share Price (SHP)
| Bid price | 1,896.00 | Open price | 1,889.00 |
|---|---|---|---|
| Ask price | 1,897.00 | Prev close | 1,897.00 |
| High price | 1,906.00 | Spread | 0.05% |
| Low price | 1,884.00 | Volume | 1,294,794 |
Register now for FREE live Shire share prices, Shire stock quotes, charts, trades and FREE Shire company fundamentals, market news and much much more. Why not upgrade to a premium service and get Shire Level 2 Data, indepth research tools and investor commentary for Shire (SHP) and other London Stock Exchange equities.
Shire Share Price Chart
Register now for FREE Shire share price charts
Shire Share Price Information
| Name | Shire | Epic | SHP |
|---|---|---|---|
| Activites | Specialty Pharmaceuticals accounted for 83% of 2008 revenues and Human Genetic Therapies, 13% | Reuters | SHP.L |
| ISIN | JE00B2QKY057 | Google Finance | LON:SHP |
| Share Price (p) | 1,897.00 | Prev. Share Price (p) | 1,897.00 |
|---|---|---|---|
| Shares in Issue (m) | 563 | Market Cap (£m) | 10,559 |
| PE Ratio (x) | 23.00 | Div per share (p) | 8.00 |
| Div yield (%) | 0.50 | Div cover (x) | 11.72 |
| EPS (p) | 97.50 | PEG | 1.39 |
Register now for FREE Shire company fundamentals
Shire Director Deals
| Dec.Date | Type | Director | Pos | No. of Shares |
|---|---|---|---|---|
| 03/04/2012 | TIN | Graham Hetherington | FD | 9,007 |
| 03/04/2012 | TIN | Angus Russell | CEO | 37,814 |
| 03/04/2012 | SELL | Angus Russell | CEO | 12,264 |
| 03/04/2012 | SELL | Angus Russell | CEO | 4,659 |
| 22/02/2012 | TIN | Graham Hetherington | FD | 76,318 |
Shire Company News
Block listing six monthly return
Block listing six monthly return May 23, 2012 - Shire plc (LSE: SHP, NASDAQ: SHPGY) Name of applicant: Shire plc Name of scheme: 2000...
Broker News & Views
Merrill Lynch upgrades Marks & Spencer from neutral to buy, target price unchanged at 400p. Merrill Lynch upgrades Man Group from neutral to overweight. Merrill Lynch upgrades Debenhams from neutral to buy, target price raised from 87p to 90p. Finncap upgrades ARM Holdings from hold to buy,...
Total Voting Rights
Total Voting Rights May 1, 2012 - Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, in accordance with DTR 5.6.1 of the FSA's Disclosure and Transparency Rules, notifies the market of the following: At close of business on April 30, 2012, Shire plc's issued...
Register now for FREE Shire company news
Shire Share Price Discussions
class pharma company - slipped under the radar (SHP)
why on earth has this exciting pharma company been ignored her for the last 3.5 years? ...... lots has happened in that time, generally for the better on the longer view ..... from a purely chart point of view, the 200 mda is rising quite steadily, with sp recovering well after a sharp fall,...
class pharma company - slipped under the radar (SHP)
why on earth has this exciting pharma company been ignored her for the last 3.5 years? ...... lots has happened in that time, generally for the better on the longer view ..... from a purely chart point of view, the 200 mda is rising quite steadily, with sp recovering well after a sharp fall, and...
Shire in drug refusal rumours (shp)
There is no smoke without fire, and keen eyed observers will note that Shire Pharmaceutical s is down 7.7% this morning at 372p, having been 13% down at one point. The word in the market is that its application to the US FDA for approval of its Adderall XR treatment for Attention Deficit...
Register now for FREE Shire share price discussions